Novavax launches late-stage trials in U.S. for Covid vaccine candidate

Novavax has officially hit go on advanced trials of its coronavirus vaccine candidate in the U.S. and Mexico, working with up to 114 sites in this country to enroll up to 30,000 total participants. These latest trials follow late-stage trials already underway in the U.K., as well as phase 2 trials in South Africa and phase 1/2 trials in U.S. and Australia. The company said it hopes to get data from those clinical tests as soon as the first quarter of 2021, depending on enrollment and transmission…